DermHelpCentral

Lab Testing When of Isotretinoin

Article: British Journal of Dermatology, August 2022

Is routine laboratory testing in healthy young patients taking isotretinoin necessary - a critically appraised topic
Andrew Affleck et. al.

Abstract
Adverse events were very rare (less than 1 in 10,000) and either idiosyncratic or not preventable by monitoring, were accompanied by symptoms, or occurred in identifiable predisposed individuals that may benefit from monitoring because of pre-existing conditions.

Recommendation for clinical care: We could not find evidence to support the benefit of monitoring to detect adverse events. We suggest that in healthy young people laboratory monitoring for oral isotretinoin is unnecessary and risks detecting non-serious biochemical abnormalities. However, we recognise that new information about adverse events may change that recommendation.

Br J Dermatol. 2022 Aug 20. PMID: 35986616

Common Causes of Baldness

Hair loss (alopecia) is categorized as scarring (with permanent destruction of hair follicles) or nonscarring.
Nonscarring alopecia is the most common form of hair loss and can be classified as patterned, diffuse, or focal, based on the distribution of hair loss.

The Journal of the American Medical Association had a helpful Patient Page on non-scarring alopecia inj August 2022.  Here's the link: Download Common Causes of Baldness JAMA